Improving quality and reducing inequality in heart failure

Sanjay S Bhandari1, Daniel Cs Chan1

  • 1Cardiology Specialist Registrar Glenfield Hospital, Leicester.

Insights

The British Society for Heart Failure (BSH) meeting focused on enhancing heart failure care quality and reducing health inequalities. Experts shared insights on advancing treatment and patient outcomes in heart failure management.

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Clinical Practice Improvement

Background:

  • The British Society for Heart Failure (BSH) convenes annually to discuss advancements in cardiovascular medicine.
  • Heart failure remains a significant global health challenge, necessitating continuous improvement in care.
  • Inequalities in healthcare access and outcomes persist, particularly in chronic disease management.

Purpose of the Study:

  • To summarize key discussions and findings from the 2019 BSH annual autumn meeting.
  • To highlight expert perspectives on improving the quality of heart failure care.
  • To address strategies for reducing disparities in heart failure treatment and outcomes.

Main Methods:

  • The report synthesizes presentations and discussions from leading international authorities in heart failure.
  • Key themes and expert opinions were identified and collated.
  • The focus was on practical applications for improving patient care and equity.

Main Results:

  • The meeting emphasized a commitment to enhancing the quality of services for heart failure patients.
  • Discussions centered on identifying and mitigating factors contributing to health inequalities in heart failure.
  • International experts shared best practices and innovative approaches to heart failure management.

Conclusions:

  • Improving heart failure care requires a dual focus on quality enhancement and equitable access.
  • Collaborative efforts and knowledge sharing are crucial for advancing heart failure treatment.
  • Addressing inequalities is paramount to achieving optimal outcomes for all heart failure patients.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
23
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
136
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
26
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
505
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
28
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
30